PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+10.02%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$999M
AUM Growth
+$999M
(+12%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
13.13%
Top 10 Holdings %
Top 10 Hldgs %
48.3%
Holding
166
New
40
Increased
25
Reduced
29
Closed
47
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$38M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$34.4M |
| 3 |
Insmed
INSM
|
$29.2M |
| 4 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$28.7M |
| 5 |
CELG
Celgene Corp
CELG
|
$25.9M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$21.5M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$18.5M |
| 3 |
Exact Sciences
EXAS
|
$15.7M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$10.6M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$10.4M |
Sector Composition
| 1 | Healthcare | 84.97% |
| 2 | Financials | 1.08% |
| 3 | Consumer Discretionary | 0.01% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sarepta Therapeutics
SRPT
$1.78B
| $76.2M | 7.48% | 2,558,478 -320,501 | -11% | -$9.55M |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $68.3M | 6.7% | 4,599,867 -19,500 | -0.4% | -$289K |
|
3
Talphera
TLPH
$11.1M
| $67.4M | 6.61% | 6,574,060 | – | – |
|
|
4
Vertex Pharmaceuticals
VRTX
$100B
| $44.5M | 4.37% | 470,142 -111,586 | -19% | -$10.6M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $43.6M | 4.28% | 507,488 +301,288 | +146% | +$25.9M |
|
|
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $42.3M | 4.15% | 301,333 +204,322 | +211% | +$28.7M |
|
|
7
Amicus Therapeutics
FOLD
$2.34B
| $41.2M | 4.04% | 12,339,444 +11,373,144 | +1,177% | +$38M |
|
|
QCOR
8
DELISTED
QUESTCOR PHARMA INC
QCOR
| $37M | 3.63% | 400,000 +371,400 | +1,299% | +$34.4M |
|
|
9
Insmed
INSM
$28.8B
| $36M | 3.53% | 1,800,000 +1,460,000 | +429% | +$29.2M |
|
|
DYAX
10
DELISTED
DYAX CORPORATION
DYAX
| $26M | 2.55% | 2,710,598 +147,924 | +6% | +$1.42M |
|
11
Zimmer Biomet
ZBH
$21B
| $25.2M | 2.47% | +242,500 | New | +$25.2M |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| $21.2M | 2.08% | 90,000 +60,000 | +200% | +$14.1M |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $20.9M | 2.05% | 282,000 -22,419 | -7% | -$1.66M |
|
14
Xencor
XNCR
$580M
| $20.2M | 1.98% | 1,740,621 +251,949 | +17% | +$2.93M |
|
15
Heron Therapeutics
HRTX
$207M
| $20.1M | 1.98% | 1,634,555 -127,871 | -7% | -$1.58M |
|
|
TSRO
16
DELISTED
TESARO, Inc.
TSRO
| $19.8M | 1.94% | 636,956 -593,114 | -48% | -$18.5M |
|
17
Iovance Biotherapeutics
IOVA
$807M
| $19.3M | 1.89% | 3,011,549 +11,549 | +0.4% | +$73.9K |
|
|
NEPT
18
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $18.5M | 1.81% | 6,700,444 | – | – |
|
19
PTC Therapeutics
PTCT
$3.92B
| $17.6M | 1.72% | 671,736 | – | – |
|
|
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $15.7M | 1.54% | 371,469 +121,469 | +49% | +$5.14M |
|
|
21
Exact Sciences
EXAS
$8.98B
| $15.3M | 1.51% | 901,250 -923,900 | -51% | -$15.7M |
|
22
Travere Therapeutics
TVTX
$1.56B
| $15M | 1.47% | 1,274,292 +230,000 | +22% | +$2.7M |
|
23
Acadia Pharmaceuticals
ACAD
$4.38B
| $14.8M | 1.45% | 653,000 -13,000 | -2% | -$294K |
|
24
Viatris
VTRS
$12.3B
| $14.6M | 1.43% | 282,500 +50,000 | +22% | +$2.58M |
|
|
RLYP
25
DELISTED
RELYPSA INC COM
RLYP
| $14.5M | 1.42% | 596,605 +415,405 | +229% | +$10.1M |
|